72 related articles for article (PubMed ID: 10094884)
1. Ultrastructural interactions in the microvasculature of human endometrial adenocarcinoma.
Horbelt DV; Roberts DK; Parmley TH; Delmore JE; Walker-Bupp NJ
Gynecol Oncol; 1999 Apr; 73(1):76-86. PubMed ID: 10094884
[TBL] [Abstract][Full Text] [Related]
2. Lymphangiogenesis of normal endometrium and endometrial adenocarcinoma.
Donoghue JF; Lederman FL; Susil BJ; Rogers PA
Hum Reprod; 2007 Jun; 22(6):1705-13. PubMed ID: 17347164
[TBL] [Abstract][Full Text] [Related]
3. Cellular features of endometrial hyperplasia and well differentiated adenocarcinoma using the Endocyte sampler: Diagnostic criteria based on the cytoarchitecture of tissue fragments.
Norimatsu Y; Shimizu K; Kobayashi TK; Moriya T; Tsukayama C; Miyake Y; Ohno E
Cancer; 2006 Apr; 108(2):77-85. PubMed ID: 16463402
[TBL] [Abstract][Full Text] [Related]
4. [Significance of proliferating cell nuclear antigen (PCNA) index and microvessel density (MVD) in endometrial carcinoma].
Xiao L; Tang LD
Ai Zheng; 2005 Jan; 24(1):19-22. PubMed ID: 15642194
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma.
Vaskivuo TE; Stenbäck F; Tapanainen JS
Cancer; 2002 Oct; 95(7):1463-71. PubMed ID: 12237915
[TBL] [Abstract][Full Text] [Related]
6. Production of activin A in hyperplasia and adenocarcinoma of the human endometrium.
Otani T; Minami S; Yamoto M; Umesaki N
Gynecol Oncol; 2001 Oct; 83(1):31-8. PubMed ID: 11585411
[TBL] [Abstract][Full Text] [Related]
7. The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer.
Giatromanolaki A; Bates GJ; Koukourakis MI; Sivridis E; Gatter KC; Harris AL; Banham AH
Gynecol Oncol; 2008 Aug; 110(2):216-21. PubMed ID: 18533240
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of angiogenesis, p-53 tissue protein expression and serum VEGF in patients with endometrial cancer.
Mazurek A; Pierzyński P; Kuć P; Kopinski P; Terlikowski S; Niklińska W; Trojan J; Laudański T
Neoplasma; 2004; 51(3):193-7. PubMed ID: 15254672
[TBL] [Abstract][Full Text] [Related]
9. [The morphogenetic potentials of endometrial and ovarian tumor cells when cultured on soft agar].
Semiachkina SO; Klimashevskiĭ VF; Pozharisskiĭ KM
Tsitologiia; 1992; 34(11-12):46-50. PubMed ID: 1302393
[TBL] [Abstract][Full Text] [Related]
10. New marker for blood vessels in human ovarian and endometrial cancers.
Samoszuk M; Lin F; Rim P; Strathearn G
Clin Cancer Res; 1996 Nov; 2(11):1867-71. PubMed ID: 9816142
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis and Bcl-2 protein expression in patients with endometrial carcinoma.
Mazurek A; Pierzynski P; Niklinska W; Chyczewski L; Laudanski T
Neoplasma; 2002; 49(3):149-54. PubMed ID: 12097999
[TBL] [Abstract][Full Text] [Related]
12. Urocortin expression is downregulated in human endometrial carcinoma.
Florio P; De Falco G; Leucci E; Torricelli M; Torres PB; Toti P; Dell'Anna A; Tiso E; Santopietro R; Leoncini L; Petraglia F
J Endocrinol; 2006 Jul; 190(1):99-105. PubMed ID: 16837614
[TBL] [Abstract][Full Text] [Related]
13. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
14. Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables.
Kyushima N; Watanabe J; Hata H; Jobo T; Kameya T; Kuramoto H
J Cancer Res Clin Oncol; 2002 Jun; 128(6):307-12. PubMed ID: 12073048
[TBL] [Abstract][Full Text] [Related]
15. Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: A surveillance, epidemiology, and end results population study.
Lee CM; Szabo A; Shrieve DC; Macdonald OK; Tward JD; Skidmore TB; Gaffney DK
Cancer; 2007 Nov; 110(9):2092-100. PubMed ID: 17849468
[TBL] [Abstract][Full Text] [Related]
16. Endometrial angiogenesis: from physiology to pathology.
Krikun G; Schatz F; Lockwood CJ
Ann N Y Acad Sci; 2004 Dec; 1034():27-35. PubMed ID: 15731297
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of tumor angiogenesis and thymidine phosphorylase tissue expression in patients with endometrial cancer.
Mazurek A; Kuc P; Terlikowski S; Laudanski T
Neoplasma; 2006; 53(3):242-6. PubMed ID: 16652195
[TBL] [Abstract][Full Text] [Related]
18. Expression and function of activin receptors in human endometrial adenocarcinoma cells.
Tanaka T; Toujima S; Otani T; Minami S; Yamoto M; Umesaki N
Int J Oncol; 2003 Sep; 23(3):657-63. PubMed ID: 12888901
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
[TBL] [Abstract][Full Text] [Related]
20. [Nucleolar organizers and mitotic conditions in endometrial hyperplasia and carcinomaĭ].
Ellinidi VN; Pozharisskii KM
Vopr Onkol; 1999; 45(6):636-40. PubMed ID: 10703512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
